Abstract
Background: The endogenous cannabinoid system (eCB) has been shown to play an important role in the extinction of aversive memories. AM404, the metabolite of paracetamol, was shown to enhance eCB signaling.
Objective: The present study was designed to pre-clinically evaluate the effectiveness of paracetamol against Post-traumatic stress disorder (PTSD). Methods: Contextual Fear conditioning (CFC) was used as animal model of PTSD. The behavioral and biochemical indicators of anxiety were also measured using elevated plus maze (EPM) and corticosterone levels, respectively. Results: Our data showed that the paracetamol treatment (100, 250 and 500 mg/kg) caused significant dose dependent decrease in animal’s freezing behavior in fear conditioned rats. The EPM data revealed that the treated rats spent more time in the open arm of elevated plus maze. However, the corticosterone levels remained unaltered. Conclusion: The present study provide robust evidence that the paracetamol, having established safety in humans, holds promise against PTSD and merits further investigation as potential lead compound in anti-PTSD drug development program.Keywords: Paracetamol, post-traumatic stress disorder, contextual fear conditioning, anxiety, corticosterone, flashbacks.
Letters in Drug Design & Discovery
Title:Acetaminophen (Paracetamol) Facilitated Extinction Lear ning in Contextual Fear Conditioned Rats
Volume: 14 Issue: 8
Author(s): Neelam Zaman, Hammad Ahmad, Mobasher Ali Abid, Nisar-ur-Rahman, Talat Roome and Ghulam Abbas*
Affiliation:
- Pharmacology Section, H.E.J. Research Institute of Chemistry, International Center for Chemical & Biological Sciences, University of Karachi, Karachi-75270,Pakistan
Keywords: Paracetamol, post-traumatic stress disorder, contextual fear conditioning, anxiety, corticosterone, flashbacks.
Abstract: Background: The endogenous cannabinoid system (eCB) has been shown to play an important role in the extinction of aversive memories. AM404, the metabolite of paracetamol, was shown to enhance eCB signaling.
Objective: The present study was designed to pre-clinically evaluate the effectiveness of paracetamol against Post-traumatic stress disorder (PTSD). Methods: Contextual Fear conditioning (CFC) was used as animal model of PTSD. The behavioral and biochemical indicators of anxiety were also measured using elevated plus maze (EPM) and corticosterone levels, respectively. Results: Our data showed that the paracetamol treatment (100, 250 and 500 mg/kg) caused significant dose dependent decrease in animal’s freezing behavior in fear conditioned rats. The EPM data revealed that the treated rats spent more time in the open arm of elevated plus maze. However, the corticosterone levels remained unaltered. Conclusion: The present study provide robust evidence that the paracetamol, having established safety in humans, holds promise against PTSD and merits further investigation as potential lead compound in anti-PTSD drug development program.Export Options
About this article
Cite this article as:
Zaman Neelam, Ahmad Hammad, Abid Ali Mobasher, Nisar-ur-Rahman , Roome Talat and Abbas Ghulam*, Acetaminophen (Paracetamol) Facilitated Extinction Lear ning in Contextual Fear Conditioned Rats, Letters in Drug Design & Discovery 2017; 14 (8) . https://dx.doi.org/10.2174/1570180814666170203162557
DOI https://dx.doi.org/10.2174/1570180814666170203162557 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Current Drug Safety Ca2+ Signalling in Damaged Endothelium: Do Connexin Hemichannels Aid in Filling the Gap?
Current Drug Therapy Sleep and Asthma
Current Respiratory Medicine Reviews Adverse HBOC-Endothelial Dysfunction Synergism: A Possible Contributor to Adverse Clinical Outcomes?
Current Drug Discovery Technologies Mild Parkinsonian Signs in a Hospital-based Cohort of Mild Cognitive Impairment Types: A Cross-sectional Study
Current Alzheimer Research Impact of HLA Haplotype on the Response to Antipsychotic Treatment of Schizophrenia
Current Pharmacogenomics Lobar Atrophy in Frontotemporal Dementia: Diagnostic and Prognostic Implications
Current Alzheimer Research Immunotherapies for Parkinson’s Disease: Progression of Clinical Development
CNS & Neurological Disorders - Drug Targets In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Current Pharmaceutical Design Preliminary Pharmacological Screening of Some Thiosemicarbazide, s-triazole, and Thiadiazole Derivatives
CNS & Neurological Disorders - Drug Targets Abrupt Change on the Wettability of Vapor-Deposited Thin Silane Film Upon Evaporative Drying and Annealing
Current Nanoscience Red Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update
Cardiovascular & Hematological Disorders-Drug Targets Structure and Inhibitor Binding Mechanisms of 11β -Hydroxysteroid Dehydrogenase Type 1
Current Chemical Biology Disorders of Protein Biogenesis and Stability
Protein & Peptide Letters DJ-1: A New Comer in Parkinsons Disease Pathology
Current Molecular Medicine Redox Behavior of Ceria Nanoparticles
Recent Patents on Materials Science Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry Promote Recurrent Aphthous Ulcer Healing with Low Dose Prednisolone Bilayer Mucoadhesive Buccal Film
Current Drug Delivery Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
Current Topics in Medicinal Chemistry